Madrigal Pharmaceuticals

Develops small molecule drugs for the treatment of cardiovascular and metabolic diseases and non-alcoholic steatohepatitis

placeConshohocken, Pennsylvania, United States calendar_todayFounded 2011 groups56 employees language madrigalpharma.com

Registered entities

Innovation

34 patent families (20 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 2,305 times.

YearFilings
20151
20162
20176
20188
20198
20209
202110
20228
202310
20248
20259
20265

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital240%
Private equity360%

Hiring activity

Hires periodically

11 roles tracked across 3 of the last 12 months

12 Jan 2026 · Director, Patient Access, Case Management Operations · Watertown

10 Jan 2026 · Senior Medical Advisor · Munich

13 Dec 2025 · Director Finance FranceItalySpain · Zug

5 Dec 2025 · Associate Director, Patient Support Solutions · Waltham

21 Nov 2025 · Vice President, Global Promotional Advertising and Regulatory Affairs · Conshohocken

Based on job postings tracked across public sources.

Coming soon